Search results

  1. Generalised anxiety disorder

    Everything NICE has said on managing generalised anxiety disorder in adults in primary, secondary and community care in an interactive flowchart

  2. Myeloma

    Everything NICE has said on diagnosing and managing myeloma, and preventing and managing its complications in an interactive flowchart

  3. Neurological conditions

    Everything NICE has said on neurological conditions in an interactive flowchart

  4. Eczema

    Everything NICE has said on managing atopic eczema in children up to 12 years, and treating eczema in people aged 13 years and over, in an interactive flowchart

  5. Cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis (IPG688)

    Evidence-based recommendations on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. This involves

  6. Ovarian cancer

    Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart

  7. Oesophageal and gastric cancer

    Everything NICE has said on assessing and managing non-stromal oesophageal and gastric cancer in adults

  8. Colorectal cancer

    Everything NICE has said on diagnosing and managing colorectal (bowel) cancer in an interactive flowchart

  9. Free-functioning gracilis transfer to restore upper limb function in brachial plexus injury (IPG687)

    Evidence-based recommendations on free-functioning gracilis transfer to restore upper limb function in brachial plexus injury in adults. This involves a piece o

  10. Lenalidomide maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma (TA680)

    Evidence-based recommendations on lenalidomide (Revlimid) for maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple

  11. Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing (NG190)

    This guideline sets out an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations are for adults, young people and children aged 72 hours and over. They do not cover diagnosis.

  12. Atopic eczema in under 12s: diagnosis and management (CG57)

    This guideline covers diagnosing and managing atopic eczema in children under 12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has on quality of life, in addition to its physical severity.

  13. Skin conditions

    Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart

  14. Psoriasis

    Everything NICE has said on psoriasis in an interactive flowchart

  15. Fertility

    Everything NICE has said on assessing and treating people with fertility problems in an interactive flowchart

  16. Intrapartum care

    Everything NICE has said on the care of healthy women and their babies during childbirth in an interactive flowchart

  17. Atrial fibrillation

    Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

  18. Perioperative care

    Everything NICE has said on perioperative care in adults in an interactive flowchart.

  19. Idiopathic pulmonary fibrosis

    Everything NICE has said on diagnosing and managing suspected idiopathic pulmonary fibrosis in adults in an interactive flowchart

  20. Familial breast cancer

    Everything NICE has said on assessing and managing familial breast cancer and related risks in people with a family history in an interactive flowchart

  21. Low back pain and sciatica

    Everything NICE has said on low back pain and sciatica in an interactive flowchart

  22. Foot care for people with diabetes

    Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart

  23. Safeguarding adults in care homes (NG189)

    This guideline covers keeping adults in care homes safe from abuse and neglect. It includes potential indicators of abuse and neglect by individuals or organisations, and covers the safeguarding process from when a concern is first identified through to section 42 safeguarding enquiries. There are recommendations on policy, training, and care home culture, to improve care home staff awareness of safeguarding and ensure people can report concerns when needed.

  24. Chronic heart failure

    Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart

  25. Ear, nose and throat conditions

    Everything NICE has said on ear, nose and throat conditions in an interactive flowchart

  26. Rheumatoid arthritis

    Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

  27. Dapagliflozin for treating chronic heart failure with reduced ejection fraction (TA679)

    Evidence-based recommendations on dapagliflozin (Forxiga) for symptomatic chronic heart failure with reduced ejection fraction in adults

  28. Autologous anti-CD19-transduced CD3+ cells for treating relapsed or refractory mantle cell lymphoma (TA677)

    Evidence-based recommendations on autologous anti-CD19-transduced CD3+ cells for treating relapsed or refractory mantle cell lymphoma in adults who have

  29. Non-Hodgkin's lymphoma

    Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart

  30. Faecal incontinence

    Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart

  31. In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, stroke and/or TIA), who have a recorded CVD risk assessment score (using the QRISK2 assessment tool) of more than 20% in the preceding 12 months: the percentage who are currently treated with statins (unless there is a contraindication)

    In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March...

  32. Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (TA673)

    Evidence-based recommendations on niraparib for maintenance treatment of advanced (FIGO stages 3 and 4) high-grade epithelial ovarian, fallopian tube or primary

  33. Bladder cancer

    Everything NICE has said on bladder cancer in adults in an interactive flowchart